Ameritas Investment Partners’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-413
| Closed | -$9.35K | – | 3184 |
|
2024
Q1 | $9.35K | Hold |
413
| – | – | ﹤0.01% | 2827 |
|
2023
Q4 | $5.36K | Hold |
413
| – | – | ﹤0.01% | 2960 |
|
2023
Q3 | $8.3K | Hold |
413
| – | – | ﹤0.01% | 2888 |
|
2023
Q2 | $11.1K | Hold |
413
| – | – | ﹤0.01% | 2873 |
|
2023
Q1 | $24.1K | Hold |
413
| – | – | ﹤0.01% | 2393 |
|
2022
Q4 | $20.1K | Hold |
413
| – | – | ﹤0.01% | 2564 |
|
2022
Q3 | $33K | Hold |
413
| – | – | ﹤0.01% | 2257 |
|
2022
Q2 | $27K | Hold |
413
| – | – | ﹤0.01% | 2387 |
|
2022
Q1 | $46K | Hold |
413
| – | – | ﹤0.01% | 2105 |
|
2021
Q4 | $40K | Hold |
413
| – | – | ﹤0.01% | 2275 |
|
2021
Q3 | $36K | Hold |
413
| – | – | ﹤0.01% | 2360 |
|
2021
Q2 | $64K | Hold |
413
| – | – | ﹤0.01% | 2021 |
|
2021
Q1 | $65K | Hold |
413
| – | – | ﹤0.01% | 1921 |
|
2020
Q4 | $96K | Hold |
413
| – | – | ﹤0.01% | 1605 |
|
2020
Q3 | $90K | Hold |
413
| – | – | ﹤0.01% | 1489 |
|
2020
Q2 | $117K | Buy |
413
+57
| +16% | +$16.1K | 0.01% | 1319 |
|
2020
Q1 | $103K | Buy |
356
+30
| +9% | +$8.68K | 0.01% | 1258 |
|
2019
Q4 | $94K | Hold |
326
| – | – | ﹤0.01% | 1552 |
|
2019
Q3 | $47K | Buy |
326
+58
| +22% | +$8.36K | ﹤0.01% | 1915 |
|
2019
Q2 | $24K | Hold |
268
| – | – | ﹤0.01% | 2343 |
|
2019
Q1 | $23K | Hold |
268
| – | – | ﹤0.01% | 2312 |
|
2018
Q4 | $38K | Hold |
268
| – | – | ﹤0.01% | 1967 |
|
2018
Q3 | $68K | Hold |
268
| – | – | ﹤0.01% | 1802 |
|
2018
Q2 | $68K | Buy |
268
+70
| +35% | +$17.8K | ﹤0.01% | 1804 |
|
2018
Q1 | $40K | Hold |
198
| – | – | ﹤0.01% | 2038 |
|
2017
Q4 | $28K | Hold |
198
| – | – | ﹤0.01% | 2268 |
|
2017
Q3 | $30K | Hold |
198
| – | – | ﹤0.01% | 2191 |
|
2017
Q2 | $27K | Buy |
198
+79
| +66% | +$10.8K | ﹤0.01% | 2294 |
|
2017
Q1 | $23K | Buy |
+119
| New | +$23K | ﹤0.01% | 2326 |
|